RUA Life Sciences

RUA · AIM · Health Care · mcap £19m · 29.5p

Beta Briefing, track record and bull & bear case are not ready for RUA Life Sciences yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 48 companies are already wired into a briefing: browse them.

All announcements Monitoring checked today, 15:05

All · 10 Key · 7

Date	Type	Announcement	Day
30 Jun 26	Results	Half-year Results ("RUA Life Sciences", the "Company" or the "Group")	+7.0%
02 Jun 26	Holding	Holding(s) in Company
22 May 26	Trading update	Trading update for the 6-months ended 31/03/2026 ("RUA Life Sciences", the "Company" or the "Group")	+0.0%
12 May 26		Spinout and Completion of Financing of RSH Spinout and Completion of Financing of RUA Structural Heart	+2.0%
17 Mar 26	Routine	Result of AGM
17 Mar 26	Trading update	AGM Statement and Trading Update RUA Life Sciences (AIM: RUA), the medical device businesses focused on implantable textiles and the leading biostable polymer (Elast-Eon™), provides the following update on trading and business developments since the aud	+7.7%
12 Feb 26	Routine	Posting of Annual Report and Notice of AGM
30 Jan 26	Results	Final Results ("RUA Life Sciences", the "Company" or the "Group")	−7.9%
10 Dec 25		Cancellation & Reissue Share Options ("RUA Life Sciences", the "Company" or the "Group")	+2.1%
04 Nov 25	Trading update	Trading update ("RUA Life Sciences", the "Company" or the "Group")	+6.2%

Company filings. Not investment advice.